Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer

By afschroeder • November 15, 2025

Sakowitz S, Tupper HI, Benjamin LN, Oh S, He T, Ronaghi R, Channick CL, Rosenberg BJ, Salehi-Rad R, Smith MI, Bando JM, Young TJ, Barjaktarvic I, Velez Velez MA, Gower A, Cummings AL, Goldman J, Lisberg AE, Garon EB, Yanagawa J, Cameron EA, Burt BM, Revels SL, Toste P, Lee JM, Lee A, Deng J, Lee H, Benharash P, Moghanaki D. Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer. Chest. 2025 Nov 12:S0012-3692(25)05681-8. doi: 10.1016/j.chest.2025.10.040. Epub ahead of print. PMID: 41238056.

Tags: Hematology/Oncology, Non-small cell lung cancer, Publications, Pulmonary, Critical Care & Sleep Medicine, Stereotactic Body Radiation Therapy, Surgery, Veterans Administration

Related Posts

American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults

O'Dwyer K, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer J, Hayes-Lattin[...]

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer

Zhang S, Queen KJ, Duggirala N, Yang E, Lipsyc-Sharf M, Racz J, Bennett J, Hong K, Suresh Y, Hamilton C, Pitta M, Chien N, La[...]

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Choueiri TK, Merchan J, Patnaik A, Drakaki A, Rini BI, Rha SY, Lee JL, Ornstein MC, Kumar R, Hwang C, Shao Y, Park SH, Barata[...]